市場調査レポート

商品コード

1734917

塞栓粒子市場の2032年までの予測：製品別、材料別、用途別、エンドユーザー別、地域別の世界分析

Embolization Particle Market Forecasts to 2032 - Global Analysis By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Gelfoam Particles, Gelatin Sponge Particles and Other Products), Material, Application, End User and By Geography

出版日: 2025年05月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 602,248円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 761,880円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 921,512円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,088,400円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.12円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の塞栓粒子市場は2025年に17億米ドルを占め、予測期間中にCAGR 12.7%で成長し、2032年には38億米ドルに達する見込みです。

塞栓粒子は、血管を意図的に塞ぐための塞栓術と呼ばれる医療処置で使用される小さな合成または天然材料です。これらの粒子は、腫瘍、異常増殖、出血部位などの特定部位への血流を阻害するために、カテーテルを通して標的血管に注入されます。血液の供給を制限することで、腫瘍を縮小させたり、出血を止めたり、手術中の出血を抑えたりすることができます。一般的な材料としては、ポリビニルアルコール（PVA）、微小球、ゼラチンスポンジ、金属コイルなどがあります。粒子径と材料の選択は臨床目標と標的血管の大きさに依存します。

米国がん協会（American Cancer Society, Inc.）が発表したデータによると、2024年1月には、米国で新たに約41,630例の肝臓がんがその年に診断されると推定されています。

慢性疾患の増加

がん、心血管疾患、子宮筋腫などの慢性疾患の発生率の上昇が、塞栓粒子市場の大きな成長を促しています。これらの疾患は、治療のために低侵襲処置を必要とすることが多く、塞栓粒子は異常な血流を遮断する上で重要な役割を果たします。侵襲性が低く、標的を絞った治療で回復が早い治療法に対する患者の需要が高まるにつれて、塞栓技術のニーズは拡大しています。この動向は、技術革新、投資、市場拡大を促進し、塞栓粒子を重要な治療ソリューションとして位置づけています。

塞栓術の高コスト

塞栓術の治療費が高いことが、塞栓粒子市場の成長を大きく阻害しています。高額な治療費は、特に低所得地域における患者のアクセスを制限し、全体的な需要を減少させる。さらに、ヘルスケアプロバイダーは、高い運用コストのためにこれらの高度な手技の採用に消極的である可能性があり、市場の拡大をさらに阻害しています。これは市場参入者にとって障壁となり、技術革新を遅らせ、生命を救う可能性のある治療の採用を制限します。

技術の進歩

技術の進歩は、精度、有効性、患者の安全性を高めることにより、塞栓粒子市場を大きく牽引しています。画像誘導送達システム、生体吸収性粒子、ナノテクノロジーなどの技術革新は、最小限の侵襲で標的治療を可能にし、回復時間を短縮し、転帰を改善します。このような画期的な技術は投資を呼び込み、腫瘍学、神経学、婦人科学などの臨床応用を拡大しています。ヘルスケアが個別化医療へとシフトする中、テクノロジー主導の塞栓ソリューションは優れたカスタマイズ性を提供し、世界の普及と市場成長を後押ししています。

厳しい規制要件

厳しい規制要件は、長くてコストのかかる承認プロセスを課すことにより、塞栓粒子市場の大きな妨げとなっています。FDAやEMAのような規制機関は、大規模な臨床試験と包括的な安全性データを要求し、新製品の市場参入を遅らせています。このような厳格な基準は開発コストを増大させ、特に中小規模のメーカーにとってはコンプライアンスを複雑にしています。このような障壁は技術革新を制限し、製品の入手可能性を制限し、特に新興市場において先進治療へのタイムリーなアクセスを妨げます。

COVID-19の影響

COVID-19の大流行は塞栓粒子市場を大きく混乱させ、選択的処置の遅れや入院の減少を招いた。ロックダウンとリソースの再配分はサプライチェーンを緊張させ、製造と流通の課題を引き起こしました。その結果、労働力が不足し、臨床開発活動に支障をきたしました。その結果、パンデミックのピーク時には市場の成長が鈍化しました。しかし、ヘルスケアシステムが適応し、選択的処置が再開されるにつれて、市場は回復し、拡大が続くものと思われます。

予測期間中は生分解性セグメントが最大になる見込み

生分解性セグメントは、これらの粒子が治療効果を達成した後に自然に溶解し、永久インプラントに関連するリスクを最小限に抑えることから、予測期間中に最大の市場シェアを占めると予想されます。低侵襲処置への嗜好の高まりと生体適合性への意識の高まりが需要を後押ししています。さらに、生分解性材料の進歩は治療精度と治療後の回復を向上させ、この分野を塞栓粒子産業における主要な促進要因および技術革新の触媒として位置づけています。

神経分野は予測期間中に最も高いCAGRが見込まれる

予測期間中、動静脈奇形のような神経血管障害の増加により、神経学セグメントは最も高い成長率を示すと予測されます。低侵襲手技の進歩や神経疾患に対する意識の高まりが、精密な塞栓ソリューションの需要に拍車をかけています。病院や診療所では、効果的で的を絞った治療のために塞栓粒子を採用するケースが増えており、患者の転帰を向上させています。このような神経学分野からの強い需要は、世界の塞栓技術市場の拡大、技術革新、投資にプラスの影響を与え続けています。

最大シェアの地域：

予測期間中、アジア太平洋地域は、高度なインターベンショナル・ラジオロジー手技へのアクセス改善により、最大の市場シェアを占めると予想されます。各国政府は低侵襲治療を優先しており、塞栓療法の需要を押し上げています。技術の進歩や医療ツーリズムの拡大も市場拡大に寄与しています。中国、インド、東南アジアのような新興経済諸国では、患者の予後を改善し、回復時間を短縮し、費用対効果の高いヘルスケアソリューションを推進しています。

CAGRが最も高い地域：

予測期間中、北米地域が最も高いCAGRを示すと予測されるが、これは低侵襲手技の採用が増加していることと、インターベンショナル・ラジオロジーの技術的進歩によるものです。ヘルスケア支出の増加と償還政策が市場成長をさらに後押しします。大手企業は研究開発に投資し、治療の有効性と安全性を高めています。この進歩は、患者の転帰を改善し、治療需要を加速し、世界の塞栓術技術におけるこの地域のリーダーシップを強化しています。

無料カスタマイズサービス：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、ジョイントベンチャー
買収と合併
新製品発売
事業拡大
その他の主要戦略

第11章企業プロファイリング

Boston Scientific Corporation
Medtronic plc
Terumo Corporation
Merit Medical Systems, Inc.
Cook Medical Inc.
Sirtex Medical Limited
BTG plc
Stryker Corporation
Penumbra, Inc.
Johnson & Johnson
Guerbet Group
Kaneka Corporation
Interface BIOmaterials B.V.
HENGRUI Medical
Alicon

図表

List of Tables

Table 1 Global Embolization Particle Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 3 Global Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 4 Global Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 5 Global Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 6 Global Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 7 Global Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 8 Global Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 9 Global Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 10 Global Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 11 Global Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 12 Global Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 13 Global Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 14 Global Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 15 Global Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 16 Global Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 17 Global Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 18 Global Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 19 Global Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 20 Global Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 21 Global Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 22 Global Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 23 Global Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 24 Global Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
Table 25 North America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
Table 26 North America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 27 North America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 28 North America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 29 North America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 30 North America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 31 North America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 32 North America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 33 North America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 34 North America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 35 North America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 36 North America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 37 North America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 38 North America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 39 North America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 40 North America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 41 North America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 42 North America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 43 North America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 44 North America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 45 North America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 46 North America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 47 North America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 48 North America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
Table 49 Europe Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
Table 50 Europe Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 51 Europe Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 52 Europe Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 53 Europe Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 54 Europe Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 55 Europe Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 56 Europe Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 57 Europe Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 58 Europe Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 59 Europe Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 60 Europe Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 61 Europe Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 62 Europe Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 63 Europe Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 64 Europe Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 65 Europe Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 66 Europe Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 67 Europe Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 68 Europe Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 69 Europe Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 70 Europe Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 71 Europe Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 72 Europe Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
Table 73 Asia Pacific Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
Table 74 Asia Pacific Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 75 Asia Pacific Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 76 Asia Pacific Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 77 Asia Pacific Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 78 Asia Pacific Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 79 Asia Pacific Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 80 Asia Pacific Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 81 Asia Pacific Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 82 Asia Pacific Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 83 Asia Pacific Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 84 Asia Pacific Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 85 Asia Pacific Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 86 Asia Pacific Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 87 Asia Pacific Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 88 Asia Pacific Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 89 Asia Pacific Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 90 Asia Pacific Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 91 Asia Pacific Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 92 Asia Pacific Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 93 Asia Pacific Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 94 Asia Pacific Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 95 Asia Pacific Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 96 Asia Pacific Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
Table 97 South America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
Table 98 South America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 99 South America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 100 South America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 101 South America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 102 South America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 103 South America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 104 South America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 105 South America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 106 South America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 107 South America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 108 South America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 109 South America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 110 South America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 111 South America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 112 South America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 113 South America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 114 South America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 115 South America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 116 South America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 117 South America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 118 South America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 119 South America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 120 South America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
Table 121 Middle East & Africa Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
Table 122 Middle East & Africa Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
Table 123 Middle East & Africa Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
Table 124 Middle East & Africa Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
Table 125 Middle East & Africa Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
Table 126 Middle East & Africa Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
Table 127 Middle East & Africa Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
Table 128 Middle East & Africa Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
Table 129 Middle East & Africa Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
Table 130 Middle East & Africa Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
Table 131 Middle East & Africa Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
Table 132 Middle East & Africa Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
Table 133 Middle East & Africa Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
Table 134 Middle East & Africa Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
Table 135 Middle East & Africa Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
Table 136 Middle East & Africa Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
Table 137 Middle East & Africa Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
Table 138 Middle East & Africa Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
Table 139 Middle East & Africa Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
Table 140 Middle East & Africa Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
Table 141 Middle East & Africa Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
Table 142 Middle East & Africa Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 143 Middle East & Africa Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
Table 144 Middle East & Africa Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)

Product Code: SMRC29554

According to Stratistics MRC, the Global Embolization Particle Market is accounted for $1.7 billion in 2025 and is expected to reach $3.8 billion by 2032 growing at a CAGR of 12.7% during the forecast period. Embolization particles are small synthetic or natural materials used in a medical procedure called embolization to block blood vessels deliberately. These particles are injected through a catheter into the targeted blood vessels to obstruct blood flow to specific areas, such as tumors, abnormal growths, or areas of bleeding. By restricting blood supply, embolization can shrink tumors, stop hemorrhaging, or reduce blood loss during surgery. Common materials include polyvinyl alcohol (PVA), microspheres, gelatin sponges, or metal coils. The choice of particle size and material depends on the clinical goal and target vessel size.

According to data published by the American Cancer Society, Inc., in January 2024, about 41,630 new liver cancer cases were estimated to be diagnosed in the U.S. that year.

Market Dynamics:

Driver:

Rising Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, cardiovascular conditions, and uterine fibroids is driving significant growth in the embolization particle market. These conditions often require minimally invasive procedures for treatment, where embolization particles play a crucial role in blocking abnormal blood flow. As patient demand increases for less invasive, targeted therapies with faster recovery times, the need for embolization technologies expands. This trend fosters innovation, investment, and market expansion, positioning embolization particles as a key therapeutic solution.

Restraint:

High Cost of Embolization Procedures

The high cost of embolization procedures significantly hinders the growth of the embolization particle market. Expensive treatment prices limit patient accessibility, particularly in low-income regions, reducing overall demand. Additionally, healthcare providers may be reluctant to adopt these advanced procedures due to high operational costs, further stalling market expansion. This creates a barrier for market players, slowing innovation and limiting the adoption of potentially life-saving treatments.

Opportunity:

Technological Advancements

Technological advancements are significantly driving the embolization particle market by enhancing precision, efficacy, and patient safety. Innovations such as image-guided delivery systems, bioresorbable particles, and nanotechnology enable targeted therapy with minimal invasiveness, reducing recovery time and improving outcomes. These breakthroughs attract investment and expand clinical applications across oncology, neurology, and gynecology. As healthcare shifts toward personalized medicine, technology-driven embolization solutions offer superior customization, boosting adoption and market growth globally.

Threat:

Stringent Regulatory Requirements

Stringent regulatory requirements significantly hinder the embolization particle market by imposing lengthy and costly approval processes. Regulatory bodies like the FDA and EMA demand extensive clinical trials and comprehensive safety data, delaying market entry for new products. These rigorous standards increase development costs and complicate compliance, particularly for small and mid-sized manufacturers. Such barriers restrict innovation, limit product availability, and impede timely access to advanced treatments, especially in emerging markets.

Covid-19 Impact

The COVID-19 pandemic significantly disrupted the embolization particle market, leading to delays in elective procedures and reduced hospital admissions. Lockdowns and resource reallocation strained supply chains, causing manufacturing and distribution challenges. This resulted in workforce shortages and hindered clinical development activities. Consequently, the market experienced a slowdown in growth during the peak of the pandemic. However, as healthcare systems adapt and elective procedures resume, the market is poised for recovery and continued expansion.

The biodegradable segment is expected to be the largest during the forecast period

The biodegradable segment is expected to account for the largest market share during the forecast period as these particles naturally dissolve after achieving their therapeutic effect, minimizing risks associated with permanent implants. Growing preference for minimally invasive procedures and increasing awareness of biocompatibility are fueling demand. Additionally, advancements in biodegradable materials enhance treatment precision and post-procedural recovery, positioning this segment as a key growth driver and innovation catalyst within the embolization particle industry.

The neurology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology segment is predicted to witness the highest growth rate, due to rising incidences of neurovascular disorders such as arteriovenous malformations. Advancements in minimally invasive procedures and increased awareness of neurological conditions have spurred demand for precise embolization solutions. Hospitals and clinics are increasingly adopting embolization particles for effective, targeted treatments, enhancing patient outcomes. This strong demand from the neurology field continues to positively impact market expansion, innovation, and investment in embolic technologies globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to improved access to advanced interventional radiology procedures. Governments are prioritizing minimally invasive treatments, boosting demand for embolization therapies. Technological advancements and expanding medical tourism further contribute to market expansion. This positive momentum is enhancing patient outcomes, reducing recovery times, and promoting cost-effective healthcare solutions across rapidly developing economies like China, India, and Southeast Asia.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising adoption of minimally invasive procedures, and technological advancements in interventional radiology. Growing healthcare expenditure and supportive reimbursement policies further drive market growth. Major players are investing in research and development, enhancing treatment efficacy and safety. This progress fosters better patient outcomes, accelerates procedural demand, and strengthens the region's leadership in global embolization technologies.

Key players in the market

Some of the key players profiled in the Embolization Particle Market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems, Inc., Cook Medical Inc., Sirtex Medical Limited, BTG plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Guerbet Group, Kaneka Corporation, Interface BIOmaterials B.V., HENGRUI Medical and Alicon.

Key Developments:

In February 2025, Medtronic and Philips have partnered to enhance the capabilities of over 300 clinicians in India by providing advanced training in structural heart imaging. This collaboration focuses on equipping cardiologists and radiologists with expertise in multi-modality imaging techniques, particularly echocardiography (echo) and Magnetic Resonance Imaging (MRI), to improve the diagnosis and treatment of structural heart diseases, especially among End-Stage Renal Disease (ESRD) patients.

In July 2024, Medtronic and SWIZTON Medcare have inaugurated their first collaborative vein clinic at Aveksha Hospital in Singapura, Bengaluru. This facility aims to provide accessible and advanced treatments for varicose veins, a condition affecting approximately 20% of adults globally.

Products Covered:

Radioembolization Spheres
Microspheres
Drug Eluting Beads (DEBs)
Gelfoam Particles
Gelatin Sponge Particles
Liquid Embolics
Polyvinyl Alcohol (PVA) Particles
Other Products

Materials Covered:

Biodegradable
Non-biodegradable

Applications Covered:

Oncology
Urology
Neurology
Peripheral Vascular Disease
Other Applications

End Users Covered:

Hospitals
Ambulatory Surgical Centers
Clinics
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Embolization Particle Market, By Product

5.1 Introduction
5.2 Radioembolization Spheres
5.3 Microspheres
5.4 Drug Eluting Beads (DEBs)
5.5 Gelfoam Particles
5.6 Gelatin Sponge Particles
5.7 Liquid Embolics
5.8 Polyvinyl Alcohol (PVA) Particles
5.9 Other Products

6 Global Embolization Particle Market, By Material

6.1 Introduction
6.2 Biodegradable
6.3 Non-biodegradable

7 Global Embolization Particle Market, By Application

7.1 Introduction
7.2 Oncology
7.3 Urology
7.4 Neurology
7.5 Peripheral Vascular Disease
7.6 Other Applications

8 Global Embolization Particle Market, By End User

8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers
8.4 Clinics
8.5 Other End Users

9 Global Embolization Particle Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Boston Scientific Corporation
11.2 Medtronic plc
11.3 Terumo Corporation
11.4 Merit Medical Systems, Inc.
11.5 Cook Medical Inc.
11.6 Sirtex Medical Limited
11.7 BTG plc
11.8 Stryker Corporation
11.9 Penumbra, Inc.
11.10 Johnson & Johnson
11.11 Guerbet Group
11.12 Kaneka Corporation
11.13 Interface BIOmaterials B.V.
11.14 HENGRUI Medical
11.15 Alicon

塞栓粒子市場の2032年までの予測：製品別、材料別、用途別、エンドユーザー別、地域別の世界分析

Embolization Particle Market Forecasts to 2032 - Global Analysis By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Gelfoam Particles, Gelatin Sponge Particles and Other Products), Material, Application, End User and By Geography

最大シェアの地域：

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の塞栓粒子市場：製品別

第6章 世界の塞栓粒子市場：材料別

第7章 世界の塞栓粒子市場：用途別

第8章 世界の塞栓粒子市場：エンドユーザー別

第9章 世界の塞栓粒子市場：地域別

第10章 主な発展

第11章 企業プロファイリング